What’s the development roadmap for the next decade in cell and gene therapies, and how do technologies build on one another rather than compete?

• Lessons learned from autologous CAR-T to inform next generation designs
• Accelerating allogeneic platforms into the clinic as scalable, off-the-shelf solutions
• The integration potential: how today’s allo approaches can feed into tomorrow’s in vivo delivery models
• Patient access: how to make sure patients benefit at each stage of this innovation curve